Insulin Therapy for Postreperfusion Hyperglycemia
Insulin Therapy for Postreperfusion Hyperglycemia in Liver Transplantation
Seoul National University Hospital
20 participants
May 15, 2017
INTERVENTIONAL
Conditions
Summary
Glycemic control during liver transplantation is challenging especially after reperfusion of the liver graft. Insulin dose to treat postreperfusion hyperglycemia is retrospectively analyzed using historical data. The proposed dose then is prospectively applied to the patients to assess the adequacy of the insulin dose.
Eligibility
Inclusion Criteria1
- Liver recipients who showed hyperglycemia (blood glucose >180mg/dL) after reperfusion of liver graft.
Exclusion Criteria1
- pediatric patients
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
If blood glucose level after reperfusion of liver graft exceeds 180 mg/dL, the insulin dose proposed by the linear mixed effects analysis is given as a bolus.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03152890